Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

3 terminated/withdrawn out of 9 trials

Success Rate

62.5%

-24.0% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

5(55.6%)

Phase 1

4(44.4%)

9Total

Phase 2(5)

Phase 1(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05027581Phase 2Completed

Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)

Role: collaborator

NCT02737748Phase 1Completed

TWB-103 for Adult Patients With Split-Thickness Skin Graft Donor Site Wounds

Role: collaborator

NCT02467413Phase 2Withdrawn

BAC in Patient With Alzheimer's Disease or Vascular Dementia

Role: collaborator

NCT02784964Phase 1Completed

Adipose-derived Stem Cells (ADSCs) for Knee Osteoarthritis

Role: collaborator

NCT02672436Phase 2Completed

ENERGI-F703 for Diabetic Foot Ulcers Phase II Study

Role: collaborator

NCT03351322Phase 2Completed

ENERGI-F701 for Female Hair Loss Treatment

Role: collaborator

NCT03256331Phase 1Terminated

Evaluate the Safety of BEL-X-HG in Advanced Cancer Patients

Role: collaborator

NCT02289300Phase 2Withdrawn

A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients

Role: lead

NCT03102398Phase 1Unknown

A Study to Assess the Safety and Tolerability Profile of TR399 in Healthy Volunteers and Erectile Dysfunction Patients

Role: collaborator

All 9 trials loaded